v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning Balance at Dec. 31, 2020 $ 559,441   $ 180,892 $ 24,387   $ (6,052) $ 360,214  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 47,513           47,513  
Dividends declared (6,623)           (6,623)  
Other comprehensive income, net of tax 916         916    
Repurchase of shares for tax payments related to the vesting and exercising of share-based grants (14,464)   (14,464)          
Issuance of shares upon exercise of common stock options 4,194   4,194          
Stock-based compensation expense 4,298   4,298          
Ending Balance at Mar. 28, 2021 $ 595,275   174,920 24,387   (5,136) 401,104  
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]              
Beginning Balance at Dec. 31, 2020 $ 559,441   180,892 24,387   (6,052) 360,214  
Ending Balance at Dec. 31, 2021 767,557 $ (43,693) 196,383 59,668 $ (59,668) (2,228) 513,734 $ 15,975
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 112,673           112,673  
Dividends declared (7,684)           (7,684)  
Other comprehensive income, net of tax 786         786    
Stock repurchases under buyback program (24,779)   (3,062)       (21,717)  
Repurchase of shares for tax payments related to the vesting and exercising of share-based grants (9,999)   (9,999)          
Stock-based compensation expense 5,111   5,111          
Ending Balance at Mar. 27, 2022 $ 799,972   $ 188,433 $ 0   $ (1,442) $ 612,981